SEC Form 4 · accession 0000899243-16-017832

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman · Director · 10% Owner

Period of report

Apr 6, 2016

Accepted (ET)

Apr 8, 2016 · 7:55 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001367644

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Apr 6, 2016	S	25,000	$38.50	D	1,774,073	D
Common Stock	Apr 6, 2016	S	25,000	$39.50	D	1,749,073	D
Common Stock^F2	holding	—	—		—	2,350,331	I	By Intervac, L.L.C.
Common Stock^F3	holding	—	—		—	1,524,155	I	By Biovac, L.L.C.

No Table II lines on this filing.

F1All sales listed on this Form 4 were made by the Reporting Person pursuant to a plan, adopted on February 29, 2016, that is intended to comply with Rule 10b5-1(c) under the Exchange Act.
F2Mr. El-Hibri's holdings through Intervac, L.L.C. include 1,638,403 shares of Common Stock held by Mr. El-Hibri and his wife, as tenants by the entirety, through their 37.7% equity interest in Intervac, L.L.C.; 127,721 shares held by Mr. El-Hibri's wife; and 584,207 shares held by trusts indirectly controlled by Mr. El-Hibri or his wife. Mr. El-Hibri disclaims beneficial ownership, for purposes of Section 16 of the Exchange Act or otherwise, of those shares held solely by his wife and those shares held by the trusts.
F3Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.